The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersPersonal genomics services: whose genomes?Breast cancer in the personal genomics eraEvolving approaches to the ethical management of genomic dataUsers' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal storiesThe Human Genome Project, and recent advances in personalized genomicsUsing lifetime risk estimates in personal genomic profiles: estimation of uncertaintyopenSNP--a crowdsourced web resource for personal genomicsDisentangling public participation in science and biomedicineThe Future of Children's Health in the Genomic EraViews of American OB/GYNs on the ethics of prenatal whole-genome sequencing.Direct-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare.At the cross-roads of participatory research and biomarker discovery in autism: the need for empirical dataAll your data (effectively) belong to us: data practices among direct-to-consumer genetic testing firms.Public trust in genomic risk assessment for type 2 diabetes mellitus.Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testingContribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.Clinical and public health implications of emerging genetic technologies.Debating clinical utilityMyths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics.Translating personalized medicine using new genetic technologies in clinical practice: the ethical issuesUnderstanding FDA regulation of DTC genetic tests within the context of administrative law.Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testingInformational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers.Practicing pathology in the era of big data and personalized medicineCool, but is it credible? Adolescents' and parents' approaches to genetic testing.Health system implications of direct-to-consumer personal genome testingAttitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics.Personal genetics: regulatory framework in Europe from a service provider's perspective.Ethical, legal, social, and policy implications of behavioral genetics.Modelling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex InitiativeDirect-to-consumer personalized genomic testing.Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms?Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.The Role of Regulatory Agencies and Intellectual Property: Part I.Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.Health care providers and direct-to-consumer access and advertising of genetic testing in the United StatesEthics and neuropsychiatric genetics: a review of major issues.Legislation on direct-to-consumer genetic testing in seven European countries.
P2860
Q22330767-7F792388-DE0F-46AC-99F2-2256C154DC43Q24600731-7A2CD2EC-CCB3-4895-8531-0140480D3ADCQ24602679-C881E980-4163-4433-9789-E5DFB0BAF0B3Q24618993-840CC13D-16E8-4A75-88AC-F67888359602Q24635266-4620EBDB-477F-48ED-8338-B62D4880E2C8Q26861372-64E8E79D-09E4-4B44-AEE1-3462D0F48928Q28392540-35EE70AD-D0A4-4A61-B23C-8A637933ABDCQ28657448-56670341-EB1F-40BE-BF39-90AF53A3923FQ28660335-26AAC04F-7EE7-4E6D-8449-11D8765ED72EQ29109919-5CBB2DA1-E140-4BAB-9D28-0296DA54A75EQ30151607-A0B1E7AD-B385-492F-8B3C-0D60BC82DEC4Q30474378-59E9A7B7-A72E-4FC9-B2E4-BF534EBF90E7Q31032197-8622FA01-517C-4ED9-BBDC-0C3654972E9CQ31132459-B562ECF8-C0CE-49BE-A69A-1105D0F55803Q33638867-E68002C8-E166-4790-B6B9-BDBFF001410AQ33754305-FE91B747-FD77-45D1-9678-5D49C7B0B563Q33810128-57FAADB6-8191-4352-815B-580C3B1E3BA3Q33817900-73465722-8774-46BD-BF19-B84AE6187262Q33832923-2D524776-880C-468B-B119-0702900ADEF7Q34037945-AFAF7468-4EE5-429A-AA07-B3E564E33FE7Q34159801-8FCB00E0-D530-45E5-96A2-8068D6CD9C73Q34169404-673277A1-F8B2-4FDB-B3C3-B7E324D54FC7Q34326774-3CFDCDCD-5677-4459-B6E2-8883AA988052Q34379754-9E7D9FE5-4098-4B20-8602-3C593F4616ABQ34388847-28A2CEE3-F80E-4E5F-894D-294C5B416F95Q34392748-40160125-C901-4B71-B0B3-7759D7DE9BEBQ34515586-2B73D09D-4403-4E2D-B1C2-C4B603EFDBACQ34608697-F9B31CD7-1EF5-4486-843F-7B8A59902A9EQ34694691-A956C602-98B3-4F61-BD9E-3F741957BFEFQ35211959-F084CF5F-617B-4C79-AD1A-D2BD50BCCE41Q35219030-BDFDA348-F6AD-4B0A-A740-89DF94F15111Q35230171-96702C9F-71A7-4361-BC2C-7FDBE0301064Q35286480-5C2A11E6-A3E7-4639-B1CF-8F3DCE75B22EQ35406266-0E1809E7-15C7-4CAD-A0B1-C02EF9463717Q35576348-54E39373-6DCB-4FCB-AF38-B615F838E5C1Q35795562-F538164F-9CCB-4B12-B0F0-6FED372B39CAQ35854671-97DA38F4-2855-4AED-82F8-8886C159F932Q35907523-94AC279B-3279-4D9A-94FB-B662F1F8BD5CQ35985180-BD56A035-03DF-4DC6-A4DF-D759EDE4472DQ36035698-6727A6EC-89D2-4797-9A79-83F0F86EBF54
P2860
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The current landscape for dire ...... l, ethical, and policy issues.
@en
The current landscape for dire ...... l, ethical, and policy issues.
@nl
type
label
The current landscape for dire ...... l, ethical, and policy issues.
@en
The current landscape for dire ...... l, ethical, and policy issues.
@nl
prefLabel
The current landscape for dire ...... l, ethical, and policy issues.
@en
The current landscape for dire ...... l, ethical, and policy issues.
@nl
P1476
The current landscape for dire ...... l, ethical, and policy issues.
@en
P2093
Gail Javitt
Stuart Hogarth
P304
P356
10.1146/ANNUREV.GENOM.9.081307.164319
P50
P577
2008-01-01T00:00:00Z